Mission Street and BGO have appointed contractor 8build to deliver the second phase of The Press – a new 100,000 sq ft life sciences development in Cambridge.
8build will create 64,000 sq ft of lab and office space either as a headquarters building or up to six smaller suites.
Artem Korolev, founder and CEO of Mission Street, said: “8build has the technical know-how to help us bring forward the latest phase of The Press. The pioneering, three-phase development will cater to innovative companies at every stage of their R&D journey. Thanks to our board and our incredible project team, the building’s function has been informed by industry leaders of companies in the sector.”
“We look forward to reaching the next milestone at The Press, which promises to deliver the facilities that will enable Cambridge to continue on its journey to becoming a supercluster of R&D excellence.”
Paul Norman, director at 8build, added: “The Press project signifies our commitment to pushing the boundaries of what is possible. We are excited about the opportunities it presents for innovation, collaboration, and ultimately, delivering exceptional results for our clients, Mission Street and BGO.”
